Promakhos Therapeutics
PrivateLast Round
Grant
Feb 19, 2024
Est. Valuation
$1.79M
Total Funding Raised
$594,365
Company Overview
Promakhos Therapeutics is a private biopharmaceutical company developing advanced, targeted, immune-modulating therapies for autoimmune diseases and cancer. The company's proprietary technology platform utilizes a novel class of Toll-like receptor (TLR) agonists to selectively control and rebalance the immune system. Their lead programs are focused on treating systemic lupus erythematosus and other inflammatory conditions.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Promakhos Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Promakhos Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 19, 2024 | ||||
| Grant | Jan 24, 2024 | ||||
| Grant | Sep 1, 2023 | ||||
| Seed | Oct 31, 2021 | ||||
| Accelerator | Jul 15, 2021 | ||||
Seed | Mar 13, 2021 |
Key People
Founding team and executive leadership
Promakhos Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Harvard Innovation Launch Lab | Seed |
| Harvard Innovation Labs | Seed |
| Massachusetts Life Sciences Center | Grant |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Y Combinator | Seed, Accelerator |
Promakhos Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Promakhos Therapeutics's valuation, stock price, and market status.
